These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 7828643
1. Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment. Imperato A, Obinu MC, Carta G, Mascia MS, Casu MA, Dazzi L, Gessa GL. Eur J Pharmacol; 1994 Oct 13; 264(1):55-60. PubMed ID: 7828643 [Abstract] [Full Text] [Related]
2. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. Abercrombie ED, DeBoer P. J Neurosci; 1997 Nov 01; 17(21):8498-505. PubMed ID: 9334422 [Abstract] [Full Text] [Related]
3. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL. J Pharmacol Exp Ther; 1993 Aug 01; 266(2):557-62. PubMed ID: 8102643 [Abstract] [Full Text] [Related]
5. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. Acquas E, Di Chiara G. Eur J Pharmacol; 1999 Oct 27; 383(2):121-7. PubMed ID: 10585525 [Abstract] [Full Text] [Related]
10. Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? Imperato A, Obinu MC, Dazzi L, Gessa GL. Eur J Pharmacol; 1994 Jan 14; 251(2-3):271-9. PubMed ID: 7908640 [Abstract] [Full Text] [Related]
11. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Steinberg R, Souilhac J, Rodier D, Alonso R, Emonds-Alt X, Le Fur G, Soubrié P. Neuroscience; 1998 May 14; 84(2):511-8. PubMed ID: 9539221 [Abstract] [Full Text] [Related]
12. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys. Rosenzweig-Lipson S, Bergman J. Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649 [Abstract] [Full Text] [Related]
15. Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms. Friedman E, Wang HY, Butkerait P. Neuropharmacology; 1990 Jun 01; 29(6):537-44. PubMed ID: 2200974 [Abstract] [Full Text] [Related]
18. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Bortolato M, Aru GN, Fà M, Frau R, Orrù M, Salis P, Casti A, Luckey GC, Mereu G, Gessa GL. Neuropsychopharmacology; 2005 Mar 01; 30(3):561-74. PubMed ID: 15328529 [Abstract] [Full Text] [Related]
19. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors. Hauber W. Neuroscience; 1996 Jul 01; 73(1):121-30. PubMed ID: 8783236 [Abstract] [Full Text] [Related]
20. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC. Eur J Pharmacol; 1999 Jan 01; 364(1):33-41. PubMed ID: 9920182 [Abstract] [Full Text] [Related] Page: [Next] [New Search]